In a historic move, Canada has passed the first phase of the Pharmacare Act, introducing universal access to essential medications, including contraception and diabetes treatments. This legislation marks a significant step in expanding the country’s healthcare system and ensuring all Canadians have access to the medications they need, regardless of income or where they live.

The Pharmacare Act, which received Royal Assent this week, immediately came into force, signaling the beginning of what is expected to be a comprehensive, national pharmacare program. The federal government has committed to working with provinces and territories to establish bilateral agreements that will provide universal, single-payer access to a range of medications. In this first phase, up to nine million women and gender-diverse individuals will receive free contraception, and the 3.7 million Canadians living with diabetes will have access to essential medications to manage their condition.

“Everyone in Canada deserves access to the care they need, including prescription medications,” said Health Minister Mark Holland. “Our plan for universal access to contraception means reproductive freedom and choice, while access to diabetes medications is a transformational step towards improving health outcomes and health equity in Canada.”

The Pharmacare Act also sets the stage for long-term healthcare reforms. Under the new law, Canada’s Drug Agency will develop a list of essential drugs and related products, creating a national formulary. This bulk purchasing strategy is designed to reduce drug prices across the country, making medications more affordable for all Canadians.

“This program is a game changer for people like me living with diabetes,” said Sandra Lewis, a Toronto resident. “Knowing that my medications will be covered is a huge relief. It’s one less thing to worry about while managing my health.”

Beyond direct coverage, the government has pledged to work closely with Indigenous communities, provinces, and other stakeholders to ensure the program is inclusive and meets the diverse needs of all Canadians. Health experts have hailed the program as a critical step in achieving health equity, particularly for low-income individuals and those without private insurance.

The passage of the Pharmacare Act reflects Canada’s commitment to improving public health and signals a new era in healthcare access. With other countries still struggling with the rising cost of medications, Canada’s pharmacare plan stands as an example of what can be achieved through political will and collective action.

For millions of Canadians, this legislation brings hope for a healthier, more equitable future. As the government continues to expand the program, the Pharmacare Act may well become a model for nations worldwide striving to improve access to life-saving medications.